Compare MLAB & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLAB | MCS |
|---|---|---|
| Founded | 1982 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Movies/Entertainment |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 479.7M |
| IPO Year | 1995 | 1994 |
| Metric | MLAB | MCS |
|---|---|---|
| Price | $75.47 | $16.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $94.00 | $23.75 |
| AVG Volume (30 Days) | 81.0K | ★ 134.4K |
| Earning Date | 05-04-2026 | 05-29-2026 |
| Dividend Yield | 0.74% | ★ 1.84% |
| EPS Growth | ★ 99.24 | N/A |
| EPS | ★ 1.95 | 0.77 |
| Revenue | N/A | ★ $758,458,000.00 |
| Revenue This Year | $6.07 | $11.78 |
| Revenue Next Year | $5.41 | $3.09 |
| P/E Ratio | $44.66 | ★ $22.50 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $59.63 | $12.85 |
| 52 Week High | $130.12 | $18.80 |
| Indicator | MLAB | MCS |
|---|---|---|
| Relative Strength Index (RSI) | 30.62 | 56.19 |
| Support Level | $69.46 | $16.66 |
| Resistance Level | $81.62 | $18.09 |
| Average True Range (ATR) | 4.17 | 0.64 |
| MACD | -1.81 | 0.03 |
| Stochastic Oscillator | 11.80 | 55.08 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.